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Abstract
Background and Objective: Exposure to ambient particles has been shown to be responsible for cardiovascular
effects, especially in elderly with cardiovascular disease. The study assessed the association between deceleration
capacity (DC) as well as heart rate variability (HRV) and ambient particulate matter (PM) in patients with coronary
artery disease (CAD).
Methods: A prospective study with up to 12 repeated measurements was conducted in Erfurt, Germany, between
October 2000 and April 2001 in 56 patients with physician-diagnosed ischemic heart disease, stable angina pectoris
or prior myocardial infarction at an age of at least 50 years. Twenty-minute ECG recordings were obtained every
two weeks and 24-hour ECG recordings every four weeks. Exposure to PM (size range from 10 nm to 2.5 μm), and
elemental (EC) and organic (OC) carbon was measured. Additive mixed models were used to analyze the
association between PM and ECG recordings.
Results: The short-term recordings showed decrements in the high-frequency component of HRV as well as in
RMSSD (root-mean-square of successive differences of NN intervals) in association with increments in EC and OC 0-
23 hours prior to the recordings. The long-term recordings revealed decreased RMSSD and pNN50 (% of adjacent
NN intervals that differed more than 50 ms) in association with EC and OC 24-47 hours prior to the recordings. In
addition, highly significant effects were found for DC which decreased in association with PM2.5, EC and OC
concurrent with the ECG recordings as well as with a lag of up to 47 hours.
Conclusions: The analysis showed significant effects of ambient particulate air pollution on DC and HRV
parameters reflecting parasympathetic modulation of the heart in patients with CAD. An air pollution-related
decrease in parasympathetic tone as well as impaired heart rate deceleration capacity may contribute to an
increased risk for cardiac morbidity and sudden cardiac death in vulnerable populations.
Background
Epidemiological studies have shown an association
between elevated levels of particulate air pollution and
increased cardiovascular and respiratory morbidity and
mortality among the elderly [1]. Furthermore, particulate
air pollution has been found to be related to changes in
autonomic nervous system function, the presence of car-
diac arrhythmias as well as the onset of myocardial
infarction (MI) [2-8].
Time- and frequency domain analysis of heart rate
variability (HRV), which enables the non-invasive assess-
ment of impaired autonomic nervous activity, can be
used to identify patients at risk for cardiac death [9]. A
decrease in HRV parameters is a strong risk factor for
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chronic heart failure [10,11]. Furthermore, phase-recti-
fied signal averaging (PRSA), developed by Bauer et al.
(2006) [12], allows periodicities to be extracted from
complex time-series that may include non-stationarities,
noise and artifacts, as well as periodic components;
while non-periodic components are eliminated. By
applying PRSA on the heart signal, the proposed para-
meter “deceleration capacity” (DC) can be derived. DC
describes the average behaviour of heart rate around
phases when the heart slows down. According to the
same authors, that impaired deceleration capacity is
both a powerful and independent parameter for risk
prediction in post-infarction individuals that is more
accurate than conventional measures of heart rate varia-
bility [13]. Moreover, the authors believe that DC pro-
vides a measure of cardiac vagal modulations. Their
findings show that the ability to slow the heart down is
more clinically important than the ability to speed it up.
To our knowledge, this marker has yet to be used in an
epidemiological setting to analyze the adverse health
effects of air pollution and may help to further disentan-
gle the effects of vagal and sympathetic modulators on
the heart.
In epidemiological studies, associations for HRV were
s e e nw i t ha c u t ee x p o s u r et oa m b i e n tP M 10 (particle
mass of particles < 10 μm) or PM2.5 (particle mass of
particles < 2.5 μm). Most associations were rather
immediate (within hours or on the same day of expo-
sure) [5,14,15], but longer time-lags were also observed
[3,16,17]. Moreover, some epidemiological studies have
associated with ambient air particles in the ultrafine
range (UFP, number count of particles < 1 μm) with
cardiac morbidity and mortality [18-20] Due to their
large surface area in relation to their volume, it has
been speculated that UFP have a greater inflammatory
effect than larger particles. In addition, it was observed
that ultrafine particles could be translocated into extra-
pulmonary organs and systemic circulation [21-24],
which led to the hypothesis that on a mass basis UFP
might be more harmful than larger particles of the same
chemical composition. Recently, a clinical study on the
autonomic modulation of the heart was performed in
which healthy volunteers were exposed to ultrafine car-
bon particles [25]. Though the changes in the ECG-
derived parameters were small, observed trends indi-
cated that some people might be particularly susceptible
to UFP exposure.
The specific objective of this study was to evaluate the
association between exposure to ambient fine and ultra-
fine ambient particles by analyzing repeatedly measured
HRV parameters in individuals with coronary artery dis-
ease (CAD). To our knowledge, this study marked the
first time that the rather new parameter DC, which goes
beyond the commonly used HRV parameters, was
included in an epidemiological setting to assess its asso-
ciation with ambient air pollution.
Materials and methods
Study population
The study was conducted in patients with CAD in
E r f u r t ,G e r m a n y ,b e t w e e nO c t o b e r1 6
th 2000 and April
27
th 2001. The city, located 200 m above sea level and
mainly surrounded by a 100 m high ridge except
towards the North, had a population of approximately
200,000 at that time. These geographic conditions favor
wintertime inversions, which result in elevated levels of
ambient air pollution. Traffic, heating, energy produc-
tion, and long-range transport are the major sources of
ambient air pollution.
Study participants were recruited through a local cardi-
ologist. They were required to be males aged 50 or more
with physician-diagnosed ischemic heart disease, stable
angina pectoris or prior MI (more than three months
ago). Based on the study objectives, current smokers,
individuals with pacemakers, bundle-branch block, type 1
diabetes, recent MI, bypass-surgery or balloon dilatation
(less than three months ago) and patients on anti-coagu-
lation therapy were excluded from participation. Of the
61 recruited subjects, 56 met the inclusion criteria for the
ECG analyses. Three patients with bundle-branch blocks
had to be excluded, as well as one who had constant
arrhythmia and one who was not compliant. Written
consent was obtained from each subject. The study pro-
tocol was approved by the German Ethics Commission
“Bayerische Landesaerztekammer”.
Clinical visits
A total of 12 clinical visits were scheduled for each par-
ticipant - one every two weeks on the same day at the
same time of the day to control for weekly and diurnal
patterns of the assessed parameters. Before the first
examination a baseline questionnaire was administered
to obtain demographic information, health status, pul-
monary and cardiac symptoms, medication use, smoking
history, exposure to environmental tobacco smoke
(ETS), living conditions and indoor and outdoor sources
of particulate air pollution. Each visit included a short
interview to assess potential confounders and to collect
information on current health status and changes in
medication. Participants in addition kept a daily diary
with information on times spent in smoke-filled rooms
and times spent in traffic using a car, bus, tram or taxi.
ECG recordings
ECGs were recorded with a 12-lead Mortara H12 recor-
der (Mortara Instrument, Milwaukee, USA) using a digi-
tal sampling rate of 180 samples/sec per channel. The
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period of rest in supine position with spontaneous
breathing. Every four weeks after the short ECG record-
ings had been made, the study subjects underwent 24-
hour Holter monitoring and were advised to keep activ-
ity diaries, which included the time, duration and type
of each activity during the monitoring period. Thus,
during the six months of the protocol, each subject was
supposed to have twelve short and six long Holter
recordings paralleled by air pollution monitoring.
ECG parameters
The ECG recordings were analyzed at the University of
Rochester Medical Center, (Rochester, NY) for comput-
ing the HRV parameters and at the First Medical Clinic
of the Munich University of Technology and German
Heart Center Munich, Germany, for measuring DC. For
the analysis, the first minute of the 6-minute period was
discarded to avoid carry-over effects from previous min-
utes. For the 24-hour recordings, the entire recording
was included in the analysis. Only normal sinus beats
were used to calculate HRV - artifacts and ectopic beats
were excluded after scanning and manual editing of the
QRS complexes. Then, the tachograms (curves describ-
ing the length of the successive RR intervals across the
analyzed period) were exported to be processed by com-
puter algorithms providing both time and frequency
domain HRV parameters. The list of HRV parameters
included in this analysis was computed according to the
current standard described in the recommendation of
the Task Force of the European Society of Cardiology
and the North American Society of Pacing and Electro-
physiology [26].
Average heart rate (HR) is expressed in number of
cardiac beats per minutes such as 60/RR when RR
intervals are measured in seconds. The time domain
HRV parameters included SDNN, RMSSD and pNN50
where SDNN is the standard deviation of RR intervals
on a given period for all normal-to-normal beats
(NN), RMSSD is the root means square of successive
differences in RR values, and pNN50 is the percentage
of adjacent RR intervals which differ more than 50 ms.
The frequency domain HRV parameters used in the
analysis were computed using the power spectral den-
sity method of the tachograms based on fast Fourier
transformation. The power of the estimated spectrum
was measured into the so-called low-frequency (LF,
0.04-1.5 Hz) and high-frequency (HF, 0.15-0.40 Hz)
bandwidths. These measurements were normalized
(LFn and HFn) with LFn = LF/(TP-VLF) and HFn =
HF/(TP-VLF) where VLF represents the energy in the
very-low-frequency bands (0.003-0.04 Hz) and TP the
power of the total spectrum. LFn and HFn have no
unit (n.u.).
F o rt h e5 - m i n u t eE C G sw ea n a l y z e dH R ,H F ,L Fa n d
RMSSD. In association with air pollution, only the nor-
malized frequency domain parameters HFn and LFn
were used. For the 24-hour ECGs HR, SDNN, RMSSD
and pNN50 were computed.
To assess DC from the 24-hour ECGs, the signal pro-
cessing technique of PRSA was used to process
sequences of NN intervals from pre-discharge Holter
recordings. The technique provided separate characteri-
zation of deceleration-related and acceleration-related
modulations, quantified by deceleration capacity and
acceleration capacity. Details on the methodology can
be found in Bauer et al. (2006)[12]. For the analysis with
air pollution, only DC was used as Bauer et al. (2006)
[13] showed that mechanisms which slow the heart
down are clinically more important than those that
speed it up and that DC was suitable as a screening
method with high prognostic value.
Air pollution monitoring
The concentrations of ambient air pollutants were mea-
s u r e da taf i x e dm o n i t o r i n g site representing urban
background levels. The Erfurt Aerosol Measurement
Site and its equipment have been described in detail
elsewhere [27]. Briefly, we sampled the particle size dis-
tribution with a mobile aerosol spectrometer for parti-
cles of a size range between 0.01 μma n d2 . 5μm.
Hourly number concentrations for ultrafine particles
(UFP, 0.01-0.1 μm) were calculated from the spectra.
Moreover, hourly mass concentrations of particles with
a size range between 0.01 μma n d2 . 5μm( P M 2.5)w e r e
calculated assuming spherical particles with an esti-
mated mean density of 1.53 g/cm
3. Elemental carbon
(EC) and organic carbon (OC) were determined hourly
from an ambient carbon monitor (5400, R&P, Inc.,
Albany, NY, USA) only after December 17
th 2000. The
continuous data on meteorological variables such as
temperature, barometric pressure and relative humidity
were collected from existing networks [27]. Missing
values for UFP and PM2.5, temperature and relative
humidity were either replaced based on corrected paral-
lel measurements (temperature, relative humidity) or
imputed by semiparametric regression models based on
data from other devices (UFP, PM2.5) [27]. The semi-
parametric model allowed for the inclusion of a smooth
function of time to account for temporal variations in
the measurements. The Goodness of Fit values were
0.94 and 0.88 for the UFP regression model and for the
PM2.5 imputations, respectively. Missing values for OC
and EC were not imputed. To determine exposure to air
pollutants prior to the recording of the short-term ECG
individual 0-5, 6-11, 12-17, 18-23, 0-23 (lag 0), 24-47
(lag 1), 48-71 (lag 2), 72-95 (lag 3), 96-119 (lag 4) and
0-119 (5-day average) hour averages of air pollution
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the recordings. For the 24-hour Holter recordings the
time at the end of the recording was taken to determine
exposure to air pollutants concurrent and prior to the
ECG-recording (lag 0 to lag 4). Average concentrations
of the air pollutants were calculated when at least 2/3 of
the hourly measurements were available.
Statistical analysis
Data were analyzed using the statistical package SAS
Version 9.1 (SAS Institute Inc., Cary, NC, USA). A
descriptive analysis of the characteristics of the study
participants was based on data obtained through the
baseline questionnaire. Mixed models with a random
participant effect and covariance structure “compound
symmetry” were used to analyze the association
between air pollutants and ECG parameters taking into
account the repeated measurements over time for each
individual. Since measurements took place two weeks
apart no adjustments for autocorrelation were neces-
sary. RMSSD of the short - as well as of the long-term
recordings was log-transformed since the residuals
were otherwise not normally distributed. Non-para-
metric smooth functions (penalized splines) were used
to explore the shape of the association between con-
founders such as trend or meteorological variables
and the dependent variable. In addition, day of the
week was also considered as a potential confounder.
Model fit was based on minimizing the Akaike Infor-
mation Criterion. Models were built for each ECG
parameter separately. The selected confounder model
for each ECG parameter can be found in the Addi-
tional File 1.
As a sensitivity analysis we re-analyzed the effects for
PM2.5 and UFP using the same reduced time-period for
which EC and OC were available. Moreover, we did a
further sensitivity analysis by excluding participants who
were taking anti-arrhythmic medication.
For effect modification, we considered body mass
index (BMI < 30 kg/m
2 vs. ≥30 kg/m
2), smoking history
(ex-smokers vs. never-smokers) and intake of beta-adre-
nergic receptor blockers (yes vs. no). Information from
the daily diaries about times spent in smoke-filled
rooms and times spent in traffic for the times during
the ECG as well as the lagged times was coded binary
(at least one hour vs. less than one hour) and used for
interaction analysis of the long-term ECGs.
Effect estimates are presented as percent change from
the mean (geometric mean for RMSSD, arithmetic mean
for all other ECG-variables) together with 95%-confi-
dence intervals based on an interquartile range (IQR:
difference between the first and the third quartile)
increase in air pollution concentration.
Results
Study population
Descriptive characteristics of the study population are
given in Table 1. The study group consisted of 56 male
volunteers with an age range of 52 to 76 years and a
BMI range of 22 to 38 kg/m
2. The majority of the parti-
cipants had prior MI and all of them had stable
ischemic heart disease. All individuals were current
non-smokers, but almost three quarters had a history of
smoking. More than two-thirds of the participants stated
that they were hypertensive. They were treated mainly
with beta-adrenergic receptor blockers or angiotensin-
converting enzyme (ACE)-inhibitors, only two patients
were on anti-arrhythmic therapy. Over three quarters of
the participants took acetylsalicylic acid (aspirin). Medi-
cation was maintained without changes during the study
Table 1 Description of the study population: 56 male
individuals with a history of coronary artery disease.
Clinical Characteristics Mean (± SD)
Age [years] 66 (± 6)
Body mass index (BMI) [kg/m
2]2 8 ( ± 4 )
Total number N
(%)
History of myocardial infarction 43 (77)
Revascularization (CABG/PTCA
a) 48 (86)
Type 2 diabetes mellitus 12 (21)
Hypertension
b 39 (70)
NYHA≥ II 17 (30)
COPD 5 (9)
Occupational
status:
- Work part time or full time 4 (7)
- Retired 49 (88)
- Unable to work or
unemployed
3 (5)
- Exposed to toxic gases, dust
or
fumes at work
1 (2)
Smoking: - Never-smoker 15 (27)
- Ex-smoker 41 (73)
Medication use: - Beta-adrenergic receptor
blockers
43 (77)
- Anti-arrhythmic therapy 2 (4)
- ACE-inhibitors 30 (54)
- Calcium-blockers 17 (30)
- Nitrates 24 (43)
- Acetylsalicylic acid (aspirin) 46 (82)
- Statins and Fibrates 29 (52)
SD: standard deviation; CABG: coronary artery bypass graft surgery; PTCA:
percutaneous transluminal coronary angioplasty; NYHA: New York Health
Association functional classification; COPD: chronic obstructive pulmonary
disease; ACE: angiotensin-converting enzyme.
aBoth procedures had to be performed more than three months prior to
enrolment.
bInformation from self-administered baseline questionnaire.
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ication (either removed or added prescription).
ECG parameters
Of the targeted 672 clinical visits with 336 planned long-
term ECG recordings, 625 5-minute ECG recordings and
254 24-hour recordings were available for the analysis of
HRV after removing recordings based on exclusion cri-
teria or poor quality. Table 2 shows the descriptive analy-
sis of the ECG parameters across all observations for
both the short-term as well as the long-term recordings.
For the 5-minute ECGs the correlation between the mar-
kers was low to moderate with the highest value being
0.7 between HF power and LF power. On average the 24-
hour ECGs were slightly higher correlated; the highest
correlation was found between RMSSD and pNN50 with
0.8. As expected, the deceleration capacity was negatively
correlated with HR (r = -0.7).
Air pollutants
A description of particulate and gaseous air pollutants as
well as of meteorological variables is shown in Table 3.
The time-series of the study period for UFP, PM2.5 and
temperature can be found in Henneberger et al. (2005)
[28]. Mean 24-hour concentrations of PM2.5 were 20
μg/m
3, which is above annual average U.S. National
Ambient Air Quality Standard (NAAQS) of 15 μg/m
3,
but below the new suggested EU Air Quality Standards
directive of 25 μg/m
3 to be met by January 2015. On 29
days of the study period (15%, all in the winter) 24-hour
PM2.5 concentrations were above the current 24-hour
U.S. NAAQS of 35 μg/m
3 for PM2.5.S of a r ,n oE U
directive exists regarding 24-hour averages.
Association between air pollution and ECG parameters
Regression of frequency domain HRV parameters and
RMSSD during the 5-minute period of spontaneous
breathing in supine position revealed decrements in
RMSSD and HFn within the first 24 hours of exposure
associated with increments in EC and OC (Table 4).
These decrements were found to be quite consistent over
the four 6-hour lag-periods (Figure 1). For HR a slight
increase was seen only in association with UFP in the 12-
17 hours prior to the recording (Figure 1). No effects
were observed for LFn or in association with PM2.5.
Results of the 24-hour ECG recordings in association
with 24-hour mean particulate air pollutants are given
in Table 4. RMSSD decreased in association with
increasing EC and OC averages during the 24-47 hours
before the ECG recording. In the same time-frame
pNN50 showed even stronger decreases - also with EC
and OC. In addition, DC decreased consistently in asso-
ciation with concurrent PM2.5, EC and OC averages as
well as with lag 0 and lag 1 (Figure 2). DC-effects were
highly significant and most consistent over different
time-lags. No effects were found for HR or SDNN or in
association with UFP.
The sensitivity analyses for the effects of PM2.5 and
UFP in the same reduced time-period in which EC and
OC were available showed no appreciable changes in
effect estimates. On average, the associations became
even slightly stronger but with wider confidence
Table 2 Description and correlation of analyzed ECG-Parameters.
Variable N Mean (± SD) Min. 25% Median 75% Max. IQR Spearman correlation coefficient
a
5 minutes spontaneous breathing in supine position
HR HF power HFn LF power LFn
HR [beats/min] 625 64.7 (± 9.9) 46.6 56.9 63.1 70.1 103.5 13.2 1
HF power [ms
2] 625 669.9 (± 3348.4) 3.6 16.4 40.4 202.4 70263 185.9 -0.4 1
HFn [n.u.] 625 0.2 (± 0.2) 0.0 0.1 0.2 0.3 0.9 0.3 -0.1 0.5 1
LF power [ms
2] 625 519.2 (± 1378.3) 3.3 63.4 145.5 357.8 21807.3 294.4 -0.4 0.7 0.1 1
LFn [n.u.] 625 0.4 (± 0.2) 0.0 0.2 0.4 0.6 1.0 0.3 -0.2 -0.1 0.30 0.3 1
RMSSD [ms] 625 40.8 (± 52.9) 4.5 14.7 22.3 40.7 462.4 26.0 -0.4 0.7 0.4 0.6 0.0
24-hour recordings
HR SDNN RMSSD pNN50
HR [beats/min] 254 69.3 (± 9.0) 50.4 62.7 69.0 74.7 94.2 12.0 1
SDNN [ms] 254 124.9 (± 33.6) 59.8 101.3 122.6 147.0 222.7 45.7 -0.4 1
RMSSD [ms] 254 42.9 (± 34.9) 9.9 22.2 31.3 49.8 292.1 27.6 -0.5 0.4 1
pNN50 [%] 254 2.8 (± 3.9) 0.0 0.0 1.0 4.0 18.0 4.0 -0.5 0.6 0.8 1
DC [ms] 254 5.6 (± 2.6) 0.3 3.8 5.3 7 21.1 3.2 -0.7 0.4 0.4 0.3
SD: standard deviation; IQR: interquartile range; HR: heart rate, HF: high-frequency, HFn: normalized high-frequency; n.u.: no unit; LF: low-frequency, LFn:
normalized low-frequency; RMSSD: square root of the mean square of successive differences of normal-to-normal (NN) intervals, SDNN: standard deviation of NN
intervals, pNN50: percentage of adjacent NN intervals which differ more than 50 ms, DC: deceleration capacity.
aMedian of patient-specific Spearman correlation coefficients.
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th 2000 and April 27
th
2001.
Variable N Mean (± SD) Min. 25% Median 75% Max. IQR Spearman correlation coefficient
PM2.5 UFP EC OC Temperature Barometric
pressure
PM2.5 [μg/m
3]
a 198 20.3 (± 14.8) 2.8 10.0 15.3 26.2 84.0 16.2 1
UFP [n/cm
3]
b 198 11639 (± 5849) 2485 6967 10717 15299 28369 8331 0.5 1
EC [μg/m
3]
c 113 2.3 (± 2.1) 0.2 0.9 1.6 2.7 10.4 1.8 0.8 0.7 1
OC [μg/m
3]
c 113 1.4 (± 0.6) 0.3 1.0 1.3 1.7 3.4 0.7 0.7 0.6 0.9 1
Temperature [°C]
d 198 4.1 (± 4.8) -10.8 -0.6 4.4 6.6 13.2 7.1 -0.5 -0.2 -0.4 -0.3 1
Barometric pressure
[hPa]
198 973.2 (± 9.8) 949.8 966.2 972.9 980.0 995.6 13.7 0.3 0.1 0.2 0.1 -0.1 1
Relative humidity
[%]
d
198 83.5 (± 8.9) 56.5 78.5 84.5 89.1 100.0 10.6 0.5 0.2 0.4 0.3 -0.4 0.1
SD: standard deviation; IQR: interquartile range; PM2.5: mass concentration of particles < 2.5 μm diameter; UFP: number concentration of particles between 0.01
and 0.1 μm diameter; EC, OC: elemental and organic carbon.
a715 (15%) of the hourly measurements were imputed.
b621 (13%) of the hourly measurements were imputed.
cMeasurements started December 18
th 2000.
d24 (0.5%) of the hourly measurements were imputed.
Table 4 Effect estimates (with 95%-confidence intervals) of particulate air pollution on heart rate variability
parameters per interquartile range increase in the respective pollutant.
PM2.5 UFP EC OC
Hours before recording
5 minutes of spontaneous
breathing in supine position
HFn %-change of the arithmetic mean per increase in IQR pollutant (95%-CI)
0 - 23 h -3.6 (-11.6;4.2) -2.2 (-10.8;6.3) -5.1 (-12.6;2.4) -9.9* (-19.2;-0.6)
24 - 47 h 0.0 (-7.0;7.1) 2.1 (-7.1;6.3) -1.0 (-8.3;6.3) -2.7 (-11.7;6.4)
RMSSD %-change of the geometric mean per increase in IQR pollutant (95%-CI)
0 - 23 h -3.5 (-8.9;2.2) -0.4 (-6.5;6.0) -7.2** (-12.0;-2.1) -8.0* (-14.0;-1.7)
24 - 47 h -0.7 (-5.8;4.7) 0.9 (-5.8;8.0) -2.9 (-7.8;2.3) -2.5 (-8.5;4.0)
24-hour recordings RMSSD %-change of the geometric mean per increase in IQR pollutant (95%-CI)
concurrent -2.5 (-8.9;4.3) 1.9 (-4.1;8.4) -2.9 (-8.0;2.4) -1.7 (-8.2;5.3)
0 - 23 h -3.7 (-10.6;3.8) 2.3 (-4.3;9.3) -2.7 (-8.4;3.3) -1.3 (-8.1;6.1)
24 - 47 h -6.0 (-12.6;1.1) -2.1 (-8.8;5.2) -5.5* (-10.7;-0.1) -5.8 (-12.1;0.9)
pNN50 %-change of the arithmetic mean per increase in IQR pollutant (95%-CI)
concurrent 0.6 (-14.9;16.1) 5.5 (-8.4;19.3) -4.7 (-17.1;7.6) -5.9 (-22.0;10.2)
0 - 23 h -6.4 (-23.1;10.2) 1.6 (-13.5;16.7) -9.6 (-23.0;3.9) -14.5 (-30.3;1.2)
24 - 47 h -16.0 (-32.4;0.4) -7.5 (-23.8;8.8) -13.8* (26.6;-1.1) -17.5* (-33.0;-2.1)
DC %-change of the arithmetic mean per increase in IQR pollutant (95%-CI)
concurrent -6.4 (-13.1;0.3) -0.8 (-7.1;5.4) -9.1** (-15.4;-2.8) -11.5** (-19.4;-3.6)
0 - 23 h -9.9* (-17.4;-2.3) -3.0 (-9.6;3.6) -11.5** (-18.1;-4.9) -14.2** (-22.2;-6.2)
24 - 47 h -11.4** (-19.4;-3.7) -5.6 (-13.2;2.0) -10.4** (-17.3;-3.5) -11.4** (-19.4;-3.4)
PM2.5: mass concentration of particles < 2.5 μm diameter; UFP: number concentration of particles between 0.01 and 0.1 μm diameter; EC, OC: elemental and
organic carbon; HFn: normalized high-frequency; IQR: interquartile range; CI: confidence interval; RMSSD: square root of the mean square of successive
differences of normal-to-normal (NN) intervals, pNN50: percentage of adjacent NN intervals which differ more than 50 ms, DC: deceleration capacity.
* p < 0.05 (significant), ** p < 0.01 (highly significant).
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DC, the same effects as in the main analyses remained
significant. The sensitivity analyses excluding the two
participants on anti-arrhythmic therapy (23 observations
for the 5-minute ECGs and 7 observations for the 24-
hour ECGs) showed slightly smaller effect estimates
with some effects changing from significant to border-
line significant. However, the order of magnitude
remained the same for all effect estimates and especially
all of the DC-effects remained very robust.
Effect modification analysis
No difference could be found between obese and non-
obese individuals with regard to air pollution health
effects. Also smoking history and beta-adrenergic
receptor blocker intake seemed not to substantially alter
the observed associations. For the 24-hour recordings,
the pNN50-effect seen with the EC- and OC-averages of
24-47 hours before the recording showed a trend
towards a stronger effect in individuals not taking beta-
adrenergic receptor blockers (data not shown). The
diary data showed that during the 254 conducted long-
term ECG measurements 22 participants had stayed in
smoke-filled rooms for at least one hour whereas 215
participants had not been exposed to ETS and 17 obser-
vations had missing information. When using this data
on ETS exposures, no significant interaction with air
pollution was found. With regard to times spent in traf-
fic, 68 participants spent less than one hour in traffic
during their long-term ECG, 169 spent more than one
hour in traffic and 17 observations had missing informa-
tion. Participants spending more than one hour in traffic
showed a trend towards stronger effects estimates espe-
cially in DC and pNN50 (Additional File 2).
Discussion
Our analyses showed an immediate decrease in HFn and
RMSSD in the 5-minute ECG-recordings for a period of
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Figure 1 Effect estimates (with 95%-confidence intervals) of
particulate air pollution for 6-hour moving averages on heart
rate and heart rate variability parameters of the 5-minute
recordings per interquartile range increase in the respective
pollutant.
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Page 7 of 12spontaneous breathing in supine position, associated
with increased levels of ambient air particles measured
as EC and OC. This indicated a shift in the sympatho-
vagal balance towards vagal withdrawal. Furthermore, in
the 24-hour recordings, we observed a delayed decrease
in RMSSD as well as in pNN50 for the same pollutants.
In addition, deceleration capacity was found to decrease
highly significantly at the same time as the 24-hour
PM2.5, OC and EC averages increased and stayed
decreased for up to 48 hours. Overall, our results in
patients with CAD indicate a consistent decrease in
parameters of HRV within 48 hours of exposure to
ambient particles for all participants regardless of their
obesity status, their history of smoking or their beta-
adrenergic receptor blocker intake. Our findings suggest
that inhaled particles may alter the balance between the
sympathetic and parasympathetic control of the heart,
resulting in a stress response that potentially leads to
arrhythmias [29].
Air pollution and HRV
Animal data support the hypothesis of the alteration of
the autonomic nervous system by air pollution [30-32].
Evidence from epidemiological studies on the effects of
ambient air pollution on HRV suggest an increase in
HR [33-35] and a decrease in SDNN and RMSSD as
well as in HF associated with particulate air pollution in
healthy elderly individuals [5,15,16,33,35-39]. Effects
were seen with either ambient or personal exposure to
PM2.5, mainly within hours or on the same day of expo-
sure. Clinical exposure studies also support these find-
ings: Devlin et al. (2003) [40] reported that elderly
subjects experienced significant decreases in HRV
immediately following exposure to concentrated air pol-
lution particles - persisting at least 24 hours after expo-
sure for some HRV parameters. However, positive
associations between air pollutants and HRV parameters
have also been shown [41,42]. However, whilst there are
some inconsistencies between studies, the general con-
s e n s u si st h a tH R Vi si m p a i r e db ye x p o s u r et oa i r
pollutants.
Susceptible subgroups
Although it has been hypothesized that individuals with
cardiovascular disease may be more susceptible to ambi-
ent air pollution, no sound body of evidence exists.
Stronger associations of particulate matter and HRV in
subjects with ischemic heart disease and hypertension
have been shown by Park et al. (2005) [16]. Inconsistent
results were found in a European multi-centre study in
CAD patients: an increase in HF and reduced LF/HF in
Erfurt, Germany, and a decreased HF and an increased
LF/HF in Helsinki, Finland [43]. Wheeler et al. (2006)
[17] found a negative relationship between SDNN and
PM2.5 in patients with cardiovascular disease whereas
patients with pulmonary disease exhibited an inverse
association. Furthermore, in a panel of coronary heart
disease patients de Hartog et al. (2009) [3] observed
associations between HRV and outdoor PM2.5 only in
the subgroup of patients without intake of beta-adrener-
gic receptor blockers at 2- and 3-day lags. Beta-blockers
can on one hand be seen as medication that stabilizes
heart rate and reduces blood pressure. They are asso-
ciated with bradi-cardiac effects and increased parasym-
pathetic innervation. But on the other hand, the
medication intake could be interpreted as a sign for the
degree of sickness of people. And sicker people might
be more susceptible to air pollution. We speculate that
this could be the reason why we do not find strong
influences v of beta-adrenergic receptor blockers in our
analyses. Furthermore, differences in timing as well as
different directions of the HRV changes might have
been due to the heterogeneity of the study populations
or to the particle sizes and composition in the various
cited studies.
Particle components
Chuang et al. (2005) [44] who analyzed the association
between particulate matter of different particle sizes and
HRV in cardiac and hypertensive patients found that
only PM in the size range from 0.3 to 1.0 μm exhibited
significant effects on HRV parameters. In our study, we
mainly found associations between EC or OC and
changes in HRV. Atmospheric carbonaceous particles
are an important component of PM2.5 and their main
fractions are EC and OC. EC is emitted directly from
combustion sources and can be seen as an effective indi-
cator of primary anthropogenic air pollutants. OC, on
the other hand, can not only be emitted from primary
emission sources (primary origin can e.g. be benzene,
toluene, ethylbenzene, xylene or polycyclic aromatic
hydrocarbons), it can also be produced from volatile
organic compound gas-to-particle conversion processes
occurring in the atmosphere. Particulate emissions from
diesel engines are composed predominantly of EC and
OC. Diesel exhaust particles contain a solid carbon core
that can aggregate redox active organics and inorganics
and can lead to the generation of reactive oxygen spe-
cies. It has been shown in various epidemiological stu-
dies so far that these soot/black smoke particles have a
detrimental effect on human health [45]. A previous
analysis in the same study population [28] demonstrated
repolarization changes associated with EC and OC.
Furthermore, a study on heart rate variability among
elderly by Schwartz et al. (2005) found stronger effects
with traffic-related particles (black carbon) [46]. In the
present study we also observed a tendency towards
stronger effects in particular with DC and pNN50 when
participants had marked in their diaries that they had
spent more than one hour in traffic. This provides an
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Page 8 of 12indication that personal activities may modify cumula-
tive personal exposure or its composition leading to
more or less detrimental effects.
Mechanistic background of air pollution effects
Several mechanisms explaining associations between
ambient air pollution and cardiovascular effects have
been suggested. Ambient air particles might activate
neural mechanisms affecting the autonomic regulation of
the heart responding through direct reflexes from irritant
receptors in the airways [47]. Other potential mechan-
isms leading to a shift in sympatho-vagal balance could
be a local or systemic inflammatory response triggering
an acute phase reaction, a change in systemic vascular
tone (endothelial dysfunction) or an ischemic response in
the myocardium as suggested by Utell et al. (2002) [48].
Furthermore, altered ion-channel functions in myocardial
cells could lead to cardiac malfunction triggered by air
pollution [49]. According to Graff et al. (2004) [50] rela-
tive metal composition largely determines the cardiac
effects of particles as metals alter the expression of ion
channels and sarcolemmal proteins relevant to electrical
remodeling. Other epidemiological studies suggest an
acute phase reaction leading to adverse cardiac outcomes.
Several authors worldwide have shown increases in
plasma viscosity and inflammatory and coagulation mar-
kers in association with air pollution [51-55] - these were
also shown for this study population [56].
Particles are also known to induce oxidative stress
[57]. Inhaled particles may on one hand lead to local
oxygen radical production in the lung due to the organic
components on the particles or by transition metal cata-
lyzed Fenton-reactions; on the other hand, ultrafine par-
ticles can be translocated into the blood circulation and
produce oxygen radicals [21-24] due to their surface
chemistry related properties through redox-sensitive
pathways [57]. A study by Schwartz et al. (2005) [58]
concluded that the effects of PM2.5 on HF seemed to be
mediated by reactive oxygen species which increased
oxidative stress. Oxidative stress can initiate further cel-
lular responses, thereby contributing to the pathogenesis
of PM-induced disease [59].
To complete the picture of air pollution-related cardi-
ovascular effects that might result in a shift of sym-
patho-vagal balance, evidence also exists that higher
ambient air particle concentrations are associated with
an ischemic response [19,60] and with endothelial dys-
function [61,62].
Implications of impaired HRV and DC
Autonomic imbalance is a major contributor to the trig-
gering of cardiac arrhythmias and, as a consequence, to
the incidence of sudden cardiac death [63]. Primarily
reduced, but also increased HRV has long been
recognized as a marker for cardiac mortality in high risk
or elderly populations [26,64-67]. Additionally, it has
been shown that HRV from 24-hour recordings was a
stronger predictor of death due to chronic heart failure
than other conventional clinical measurements [11].
Moreover, Bauer and colleagues (2006) [13] were able to
show that the relatively new parameter DC is a powerful
predictor of mortality after MI and is more accurate in
its predictive ability than conventional measures of
HRV. Patients with preserved acceleration capacity but a
lack of deceleration capacity have been found to have a
poorer outlook with regard to cardiovascular mortality.
Our study showed a decrease in HF, RMSSD and DC,
all reflecting reduced vagal tone. DC characterizes the
average capacity of the heart to decelerate the cardiac
rhythm from one beat to the next and therefore visua-
lizes the oscillations of heart rate with regard to the
ability to slow the heart down. It indicates the overall
deceleration capacity of the sinus rhythm, without
necessarily being linked to one particular physiological
regulation process (e.g. respiratory, baroreflex mediated
or circadian). In addition, it is speculated that distin-
guishing between deceleration and acceleration capacity
may be more successful in separating vagal and sympa-
thetic modulators than other HRV parameters. Clinical
and experimental studies indicate a cardioprotective role
of vagal activity [68-70] and that vagal withdrawal can
produce myocardial ischemia and possibly also be
involved in the genesis of ischemic events [71,72].
Strengths and limitations
The longitudinal approach with multiple observations
per subject had the advantage of an almost complete
follow up in all 56 participants over a period of six
months with each subject acting as his own control.
Since ECG parameters differ from person to person a
random effect for each participant was included in the
regression model, thus allowing adjustments for inter-
personal differences and medication use of the partici-
pants. Although patients with CAD are likely to be
more susceptible to air pollution, the association may be
blunted by medication intake whereby medication may
not only be a confounder but also an intermediate vari-
able, and thus difficult to control for. A further strength
was the analysis of two ECG-regimes, the 5-minute rest-
ing ECG as well as the 24-hour ECG. Both measure-
ments represented very different information as for
example in the 24-hour ECG the participants could
have been physically active or in traffic concurrent to
the ECG measurement. Moreover, the nocturnal period
was included in the 24-hour ECG during which people
in general have a very different autonomic regulation
and which is mainly driven by the parasympathetic
component.
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potential source of bias especially in time-series studies
[73]. Factors such as wind direction, climatic conditions,
long-range transport and distances from sources affect
personal exposure patterns to pollutants from ambient
sources. But any exposure misclassification would be
expected to be non-differential and thus to bias the esti-
mates towards the null. Although UFP may be more reac-
tive than the larger particles, no significant associations
were observed. UFP are usually freshly generated particles
and agglomerate rather fast. Therefore the measurement
of individual exposure to UFP by a central monitor is
prone to misclassification which can bias the results
towards zero. This would partly explain the lack of effects
associated with particles in the ultrafine range. In addition,
the times spent in traffic unfortunately did only account
for using a car, bus, tram or taxi, but not for times as a
pedestrian or on a bicycle. Therefore, possibly even more
observations would have counted as spent partly in traffic
which may have resulted in clearer differences between
the two subgroups in our interaction analysis.
Conclusions
This is one of the few epidemiological studies to report
associations of particulate air pollution on HRV in patients
with CAD, and to our knowledge, the first to include the
relatively new parameter DC. A decrease in HF and
RMSSD in the short-term recordings and a decrease in
RMSSD, pNN50 and DC in the long-term recordings were
associated with elevated concentrations of EC and OC,
both mainly indicators of vehicle traffic-related air pollu-
tion. Exposures immediately and up to 48 hours before
the recordings were responsible for these effects. The clin-
ical relevance of the effects of ambient air particles on
these autonomic function parameters is not yet established
and the exact pathomechanisms responsible for these
associations need to be elucidated. An alteration in such
parameters in association with acute exposure to ambient
air particles may be an indicator for impaired autonomic
function, potentially leading in turn to adverse cardiac
events in vulnerable people as indicated by the results of
epidemiological studies that have shown increases in car-
diac mortality and morbidity associated with decreased
HRV and DC in people with heart disease.
Additional material
Additional file 1: Selected confounder models for the ECG-
parameters in the short-term and the long-term recordings.
Additional file 2: Effect estimates with 95%-confidence intervals
based on interquartile range increases in air pollutants for the
interaction analyses with times spent in traffic (using a car, bus,
tram or taxi).
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